New drug could slash opioid use after kidney stone surgery
NCT ID NCT07654296
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a new non-opioid painkiller called suzetrigine to standard pain management can reduce opioid use and complications after ureteroscopic surgery for kidney stones. About 100 adults aged 21-80 will receive either suzetrigine or placebo alongside usual care. The goal is to lower pain, opioid consumption, and unplanned hospital visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIMODAL ANALGESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Faulkner Hospital
Boston, Massachusetts, 02130, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Two-Level nerve block better tame breast surgery pain?
- Can a softer stent spare kids from bladder spasms?
- Vacuum-Assisted sheath aims to clear kidney stones faster
- Nerve block showdown: which injection eases lung surgery pain best?
- New Non-Addictive pain drug could curb opioid dependence after surgery
- Bladder cancer surgery: do stents help or hurt?